Time Point After stopping What Trials Saw VAT and other effects trended back toward baseline
No approvals found
For systemic recovery, TB-500 remains a popular option
Key RTKs in eye include VEGF receptors (VEGFR1, VEGFR2, VEGFR3) regulating angiogenesis, FGF receptors (FGFR1-4) controlling cell proliferation and differentiation, EGF receptor family supporting epithelial cell growth, PDGF receptors modulating pericyte recruitment and vessel stabilization
Cosmetic formulations, being pre-mixed liquids or creams, might have different, often less stringent, storage recommendations for shelf-life
You can try putting a cold compress on it for a few hours and see if it helps